Effect of Bifidobacterium breve M-16V supplementation on fecal bifidobacteria in preterm neonates - A randomised double blind placebo controlled trial

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Patole, Sanjay ^a,d   Keil, Anthony D ^b   Chang, Annie ^a   Nathan, Elizabeth ^a   Doherty, Dorota ^a,c   Simmer, Karen ^a,d   Esvaran, Meera ^c   Conway, Patricia ^c  

^a KEM Hospital for Women   (Australia)

^b PATHWEST LABORATORY MEDICINE   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRIN; PLACEBO; PROBIOTIC AGENT; RIBOSOME RNA; BACTERIAL DNA; PRIMER DNA;

ABDOMINAL DISTENSION; ADVERSE OUTCOME; ARTICLE; BACTERIAL COUNT; BACTERIAL STRAIN; BACTERIAL VIABILITY; BACTERIUM DETECTION; BIFIDOBACTERIUM BREVE; CHI SQUARE TEST; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG QUALITY; DRUG SAFETY; FECES ANALYSIS; FECES LEVEL; FEMALE; GENE SEQUENCE; HUMAN; MALE; MCNEMAR TEST; MICROBIAL CONTAMINATION; NECROTIZING ENTEROCOLITIS; NEWBORN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREMATURITY; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RANK SUM TEST; RNA GENE; SEPSIS; SHELF LIFE; SUPPLEMENTATION; TREATMENT OUTCOME; VOMITING; WILCOXON SIGNED RANKS TEST; BIFIDOBACTERIUM; ENTEROCOLITIS, NECROTIZING; FECES; GENETICS; INFANT, NEWBORN, DISEASES; MICROBIOLOGY;

BASE SEQUENCE; BIFIDOBACTERIUM; DNA PRIMERS; DNA, BACTERIAL; ENTEROCOLITIS, NECROTIZING; FECES; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INFANT, PREMATURE; POLYMERASE CHAIN REACTION; PROBIOTICS; TREATMENT OUTCOME;

EID: 84897085465     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089511     Document Type: Article

References (41)

1. Neu J, Walker WA (2011) Necrotizing enterocolitis. NEJ Med 364:255-264.
2. Lin PW, Stoll BJ (2006) Necrotising enterocolitis. Lancet 368(9543):1271-83. (Pubitemid 44485800)
3. Jain L (2013) Necrotizing enterocolitis prevention: art or science? Clin Perinatol 40(1):xiii-xv. doi: 10.1016/j.clp.2013.01.002.
4. FAO/WHO Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. 2001. Available: http://www.who.int/foodsafety/publications/fs-management/en/probiotics.pdf. Accessed 2012 June 4.
5. Bermudez-Brito M, Plaza-Díaz J, Muñoz-Quezada S, Gómez-Llorente C, Gil A (2012) Probiotic mechanisms of action. Ann Nutr Metab. 61(2):160-74.
6. Claud EC, Walker WA (2008) Bacterial colonization, probiotics, and necrotizing enterocolitis. J Clin Gastroenterol 42 Suppl 2:S46-52.
7. Ganguli K, Walker WA (2012) Treatment of necrotizing enterocolitis with probiotics. Gastroenterol Clin N Am. 41:733-746.
8. Martin CR, Walker WA (2008) Probiotics: role in pathophysiology and prevention in necrotizing enterocolitis. Semin Perinatol 32(2):127-37 (Pubitemid 351381168)
9. Alfaleh K, Anabrees J, Bassler D, Al-Kharfi T (2011) Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev Mar; 16(3):CD005496.
10. Deshpande G, Rao S, Patole S, Bulsara M (2010) Updated meta analysis of probiotics for preventing necrotising enterocolitis in preterm neonates. Pediatrics 125(5): 921-30.
11. Wang Q, Dong J, Zhu Y (2012) Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: an updated meta-analysis of 20 randomized, controlled trials. J Pediatric Surg 47:241-248.
12. Deshpande GC, Rao SC, Keil AD, Patole SK (2011) Evidence-based guidelines for use of probiotics in preterm neonates. BMC Med Aug 2;9:92. doi: 10.1186/1741-7015-9-92.
13. Tarnow-Mordi WO, Wilkinson D, Trivedi A, Brok J (2010) Probiotics reduce all-cause mortality and necrotizing enterocolitis: it is time to change practice. Pediatr 125:1068-1070.
14. Barrington KJ (2011) Review: probiotics prevented necrotising enterocolitis and reduced mortality in pretneonates. Arch Dis Child Educ Pract Ed.96:199.
15. Swanson JR (2013) Necrotizing enterocolitis: is it time for zero tolerance? J Perinatol 33:1-2.
16. Janvier A, Lantos J, Barrington K (2012) The politics of probiotics: probiotics, necrotizing enterocolitis and the ethics of neonatal research. Acta Paediatr 102:116-118.
17. Umezaki H, Shinohara K, Satoh Y, Shoji H, Satoh H et al (2010) Bifidobacteria prevents preterm infants from developing infection and sepsis. Int J Probiotics Prebiotics 5(1): 33-36.
18. Satoh Y, Koichi S, Hikaru U, Shoji H, Satoh H et al (2007) Bifidobacteria prevents necrotising enterocolitis and infection in preterm infants. Int J Probiotics Prebiotics 2 (2/3): 149-54.
19. Li Y, Shimizu T, Hosaka A, Kaneko N, Ohtsuka Y et al (2004) Effects of Bifidobacterium breve supplementation on intestinal flora of low birth weight infants. Pediatr Int 46(5):509-15. (Pubitemid 39423192)
20. Wang C, Shoji H, Sato H, Nagata S, Ohtsuka Y et al (2007) Effects of oral administration of Bifidobacterium breve on fecal lactic acid and short-chain fatty acids in low birth weight infants. J Pediatr Gastroenterol Nutr 44(2):252-7. (Pubitemid 46175081)
21. Fujii T, Ohtsuka Y, Lee T, Kudo T, Shoji H et al (2006) Bifidobacterium breve enhances transforming growth factor beta1 signaling by regulating Smad7 expression in preterm infants. J Pediatr Gastroenterol Nutr 43(1):83-8. (Pubitemid 44022391)
22. Abe F, Yaeshima T, Iwatsuki K (2009) Safety evaluation of two probiotic bifidobacterial strains, Bifidobacterium breve M-16V and Bifidobacterium infantis M-63, by oral toxicity tests using rats. Bioscience Microflora 28 (1): 7-15.
23. Abe F, Muto M, Yaeshima T, Iwatsuki K, Aihara H et al (2010) Safety evaluation of probiotic bifidobacteria by analysis of mucin degradation activity and translocation ability. Anaerobe 16(2):131-6.
24. Weisburg WG, Barns SM, Pelletier DA, Lane DJ (1991) 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol. 173:697-703.
25. Mättö J, van Hoek AHAM, Domig KJ, Saarela M, Florez AB et al (2007) Susceptibility of human and probiotic Bifidobacterium spp. to selected antibiotics as determined by the Etest method. Int Dairy J 17, 1123-1131. (Pubitemid 46891232)
26. Walsh MC, Kliegman RM (1986) Necrotising enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 33: 179-201 (Pubitemid 16135483)
27. Locascio M, Holgado AP, Perdigón G, Oliver G (2001) Enteric bifidobacteria: isolation from human infants and challenge studies in mice Can J Microbiol 47(11):1048-52. (Pubitemid 34003541)
28. Matsuki T, Watanabe K, Tanaka R (2003) Genus- and species-specific PCR primers for the detection and identification of bifidobacteria Current Issues Intestinal Microbiology 4(2):61-9. (Pubitemid 37121569)
29. Matsuki T, Watanabe K, Tanaka R, Fukuda M, Oyaizu H (1999) Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers. Appl Environ Microbiol 65(10): 4506-4512.
30. Schouten B, van Esch B, Hifman GA, van Doorn S, Knol J, et al (2009) Cow milk allergy symptoms are reduced in mice fed dietary synbiotics during oral sensitization with whey. J Nutr 139(7): 1398-1403.
31. Australian Government National Health and Medical Research Council. Joint NHMRC/AVCC Statement and Guidelines on Research Practice (1997). Available: http://www.nhmrc.gov.au/guidelines/publications/r0024. Accessed 2014 January 17.
32. Moher D, Schulz KF, Altman D (2001) CONSORT Group (Consolidated Standards of Reporting Trials).The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 285(15):1987-91. (Pubitemid 32366951)
33. Williams AF (1997) Role of feeding in necrotizing enterocolitis Semin Neonatol 1997;2:263-71.
34. Kitajima H, Sumida Y, Tanaka R, Yuki N, Takayama H (1997) Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 76:F101-107. (Pubitemid 28201543)
35. Mikami K, Kimura M, Takahashi H (2012) Influence of maternal bifidobacteria on the development of gut bifidobacteria in infants Pharmaceuticals 5,629-642; doi:10.3390/ph5060629
36. Martin R, Jimenez E, Heilig H, Fernandez L, Marin ML, et al (2009) Isolation of bifidobacteria from breast milk and assessment of the bifidobacterial population by PCR-denaturing gradient gel electrophoresis and quantitative real-time PCR. Appl Environ Microbiol 75:965-969.
37. Canani RB, Di Costanzo M, Leone L, Pedata M, Meli R et al (2011) Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol. 17(12): 1519-1528
38. Layden BT, Angueira AR, Brodsky M, Durai V, Lowe WL Jr (2013) Short chain fatty acids and their receptors: new metabolic targets. Transl Res 161(3):131-40.
39. Namachivayam K, Blanco CL, MohanKumar K, Jagadeeswaran R, Vasquez M et al (2013) Smad7 inhibits autocrine expression of TGF-β2 in intestinal epithelial cells in baboon necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol. 304(2):G167-80.
40. Shanahan F (2012) A commentary on the safety of probiotics. Gastroenterol Clin N Am. 41: 869-876.
41. Seale JV, Millar M (2013) Probiotics: a new frontier for infection control. J Hosp Infect. Feb 13. doi:pii: S0195-6701(13)00035-2. 10.1016/j.jhin.2013.01.005.